Scancell Holdings plc engages in the discovery and development of novel monoclonal antibodies and vaccines for the treatment of cancer in the United Kingdom. The company's products include SCIB1, a plasmid DNA vaccine, which is in Phase I/II clinical trials for the treatment of melanoma; SCIB2 to treat lung cancer antigen; and Modi-1, which is in the pre-clinical development to treat triple negative breast cancer, ovarian cancer, and sarcoma.
Read More…
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+44-115-8231863
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees19
Next Earnings DateN/A
OptionableNot Optionable
Scancell (LON:SCLP) Frequently Asked Questions
What is Scancell's stock symbol?
Scancell trades on the London Stock Exchange (LON) under the ticker symbol "SCLP."
Has Scancell been receiving favorable news coverage?
News articles about SCLP stock have been trending neutral on Friday, InfoTrie Sentiment reports. InfoTrie rates the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Scancell earned a media sentiment score of 0.2 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Scancell.
Who are some of Scancell's key competitors?
Some companies that are related to Scancell include Matinas BioPharma (MTNB), Antibe Therapeutics (ATE), Sirona Biochem (SBM), Immutep (IMM), Medlab Clinical (MDC), OncoCyte (OCX), OncoCyte (OCX), Oxford Biodynamics (OBD), Helix Biopharma (HBP), IntelGenx Technologies (IGX), Imugene (IMU), 4d Pharma (DDDD), Orthocell (OCC), Pediapharm (PDP) and Ampio Pharmaceuticals (AMPE).
What other stocks do shareholders of Scancell own?
Who are Scancell's key executives?
Scancell's management team includes the folowing people:
- Dr. John Chiplin BPharm, MRPharmS, Ph.D., Exec. Chairman (Age 60)
- Dr. Clifford Holloway, Chief Exec. Officer
- Prof. Lindy Gillian Durrant Ph.D., Chief Scientific Officer & Director
- Dr. Sally Elizabeth Adams, Devel. Director & Director (Age 58)
- Mr. Keith Green, Director of Fin. & Admin.
How do I buy shares of Scancell?
Shares of SCLP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Scancell's stock price today?
One share of SCLP stock can currently be purchased for approximately GBX 6.10.
How big of a company is Scancell?
What is Scancell's official website?
How can I contact Scancell?
Scancell's mailing address is Department of Clinical Oncology Hucknall Road, NOTTINGHAM, NG5 1PB, United Kingdom. The company can be reached via phone at +44-115-8231863.
MarketBeat Community Rating for Scancell (LON SCLP)
MarketBeat's community ratings are surveys of what our community members think about Scancell and other stocks. Vote "Outperform" if you believe SCLP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SCLP will underperform the S&P 500 over the long term. You may vote once every thirty days.
